Symmetry Partners’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5,528	Closed	-$296K	–	632
2020 Q4	$296K	Buy	5,528 +147	+3%	+$7.87K	0.02%	525
2020 Q3	$222K	Buy	+5,381	New	+$222K	0.02%	552